financetom
Business
financetom
/
Business
/
Microsoft Unveils New AI Diagnosis Tool
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Microsoft Unveils New AI Diagnosis Tool
Jun 30, 2025 8:19 AM

10:51 AM EDT, 06/30/2025 (MT Newswires) -- Microsoft ( MSFT ) on Monday introduced a new artificial intelligence tool designed to diagnose complex medical cases more accurately than human doctors.

The Microsoft AI Diagnostic Orchestrator (MAI-DxO) tool was tested using 304 complex cases from the New England Journal of Medicine, where the system achieved the correct diagnosis in 85.5% of the cases, using OpenAI's o3 model, compared to 20% for human doctors working without external help, the company said.

The tool was developed under Microsoft's ( MSFT ) AI unit, led by Mustafa Suleyman, potentially paving the path for "medical superintelligence" that could ease doctor shortages and reduce treatment delays, multiple media outlets reported.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AAR Fiscal Q2 Adjusted Earnings, Sales Rise; Shares Climb After Hours
AAR Fiscal Q2 Adjusted Earnings, Sales Rise; Shares Climb After Hours
Jan 7, 2025
04:16 PM EST, 01/07/2025 (MT Newswires) -- AAR (AIR) reported fiscal Q2 adjusted earnings late Tuesday of $0.90 per diluted share, up from $0.81 a year earlier. Four analysts polled by FactSet expected $0.85. Sales in the three months ended Nov. 30 rose to $686.1 million from $545.4 million a year earlier. Analysts surveyed by FactSet expected $654.2 million. Shares...
Halozyme Therapeutics Insider Sold Shares Worth $500,060, According to a Recent SEC Filing
Halozyme Therapeutics Insider Sold Shares Worth $500,060, According to a Recent SEC Filing
Jan 7, 2025
04:19 PM EST, 01/07/2025 (MT Newswires) -- Jeffrey William Henderson, Director, on January 06, 2025, sold 10,000 shares in Halozyme Therapeutics ( HALO ) for $500,060. Following the Form 4 filing with the SEC, Henderson has control over a total of 43,611 shares of the company, with 43,611 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000141588925000995/xslF345X05/form4-01072025_090159.xml ...
Personalis Reports Lower Preliminary Revenue for Q4
Personalis Reports Lower Preliminary Revenue for Q4
Jan 7, 2025
04:18 PM EST, 01/07/2025 (MT Newswires) -- Personalis ( PSNL ) reported late Tuesday preliminary Q4 revenue of $16.8 million, down from $19.7 million a year earlier. Analysts polled by FactSet expected $15.5 million for the quarter ended Dec. 31. ...
P10 Appoints Andrew Corsi as Chief Accounting Officer
P10 Appoints Andrew Corsi as Chief Accounting Officer
Jan 7, 2025
04:16 PM EST, 01/07/2025 (MT Newswires) -- P10 (PX) said in a Tuesday filing its board appointed Andrew Corsi as chief accounting officer on Jan. 1. Corsi succeeds Amanda Coussens, who will continue to serve as chief financial officer and principal financial officer, the company said. Corsi previously served as P10's corporate controller, the company added. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved